FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 8401

FusionGeneSummary for CREB3L2_CDKN1A

check button Fusion gene summary
Fusion gene informationFusion gene name: CREB3L2_CDKN1A
Fusion gene ID: 8401
HgeneTgene
Gene symbol

CREB3L2

CDKN1A

Gene ID

64764

1026

Gene namecAMP responsive element binding protein 3 like 2cyclin dependent kinase inhibitor 1A
SynonymsBBF2H7CAP20|CDKN1|CIP1|MDA-6|P21|SDI1|WAF1|p21CIP1
Cytomap

7q33

6p21.2

Type of geneprotein-codingprotein-coding
Descriptioncyclic AMP-responsive element-binding protein 3-like protein 2B-ZIB transcription factorBBF2 human homolog on chromosome 7FUS/BBF2H7 proteinTCAG_1951439basic transcription factor 2cAMP-responsive element-binding protein 3-like protein 2cyclin-dependent kinase inhibitor 1CDK-interacting protein 1CDK-interaction protein 1DNA synthesis inhibitorcyclin-dependent kinase inhibitor 1A (p21, Cip1)melanoma differentiation associated protein 6wild-type p53-activated fragment 1
Modification date2018052320180527
UniProtAcc

Q70SY1

P38936

Ensembl transtripts involved in fusion geneENST00000330387, ENST00000456390, 
ENST00000452463, ENST00000458726, 
ENST00000468127, 		ENST00000448526, 
ENST00000244741, ENST00000405375, 
ENST00000373711, ENST00000478800, 
Fusion gene scores* DoF score11 X 10 X 3=3302 X 3 X 1=6
# samples 133
** MAII scorelog2(13/330*10)=-1.34395440121736
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(3/6*10)=2.32192809488736
Context

PubMed: CREB3L2 [Title/Abstract] AND CDKN1A [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotation
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneCREB3L2

GO:0045893

positive regulation of transcription, DNA-templated

17178827

TgeneCDKN1A

GO:0000082

G1/S transition of mitotic cell cycle

10208428

TgeneCDKN1A

GO:0006977

DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest

15149599

TgeneCDKN1A

GO:0007050

cell cycle arrest

15149599

TgeneCDKN1A

GO:0008285

negative regulation of cell proliferation

10208428|15149599

TgeneCDKN1A

GO:0030308

negative regulation of cell growth

10208428

TgeneCDKN1A

GO:0042326

negative regulation of phosphorylation

10208428

TgeneCDKN1A

GO:0045860

positive regulation of protein kinase activity

22869755


check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChiTaRS3.1BC037414CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
intron-3CDSENST00000330387ENST00000448526CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000330387ENST00000244741CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000330387ENST00000405375CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000330387ENST00000373711CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3UTRENST00000330387ENST00000478800CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000456390ENST00000448526CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000456390ENST00000244741CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000456390ENST00000405375CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000456390ENST00000373711CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3UTRENST00000456390ENST00000478800CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000452463ENST00000448526CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000452463ENST00000244741CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000452463ENST00000405375CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000452463ENST00000373711CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3UTRENST00000452463ENST00000478800CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000458726ENST00000448526CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000458726ENST00000244741CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000458726ENST00000405375CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000458726ENST00000373711CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3UTRENST00000458726ENST00000478800CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000468127ENST00000448526CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000468127ENST00000244741CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000468127ENST00000405375CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3CDSENST00000468127ENST00000373711CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+
intron-3UTRENST00000468127ENST00000478800CREB3L2chr7

137565216

-CDKN1Achr6

36652129

+

Top

FusionProtFeatures for CREB3L2_CDKN1A


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
CREB3L2

Q70SY1

CDKN1A

P38936

Transcription factor involved in unfolded proteinresponse (UPR). In the absence of endoplasmic reticulum (ER)stress, inserted into ER membranes, with N-terminal DNA-bindingand transcription activation domains oriented toward the cytosolicface of the membrane. In response to ER stress, transported to theGolgi, where it is cleaved in a site-specific manner by residentproteases S1P/MBTPS1 and S2P/MBTPS2. The released N-terminalcytosolic domain is translocated to the nucleus to effecttranscription of specific target genes. Plays a critical role inchondrogenesis by activating the transcription of SEC23A, whichpromotes the transport and secretion of cartilage matrix proteins,and possibly that of ER biogenesis-related genes (By similarity).In a neuroblastoma cell line, protects cells from ER stress-induced death (PubMed:17178827). In vitro activates transcriptionof target genes via direct binding to the CRE site(PubMed:17178827). {ECO:0000250|UniProtKB:Q8BH52,ECO:0000269|PubMed:17178827}. May be involved in p53/TP53 mediated inhibition ofcellular proliferation in response to DNA damage. Binds to andinhibits cyclin-dependent kinase activity, preventingphosphorylation of critical cyclin-dependent kinase substrates andblocking cell cycle progression. Functions in the nuclearlocalization and assembly of cyclin D-CDK4 complex and promotesits kinase activity towards RB1. At higher stoichiometric ratios,inhibits the kinase activity of the cyclin D-CDK4 complex.Inhibits DNA synthesis by DNA polymerase delta by competing withPOLD3 for PCNA binding (PubMed:11595739).{ECO:0000269|PubMed:11595739, ECO:0000269|PubMed:8242751,ECO:0000269|PubMed:9106657}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for CREB3L2_CDKN1A


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.

* Fusion transcript sequences (only coding sequence (CDS) region).

* Fusion transcript sequences (Full-length transcript).

Top

FusionGenePPI for CREB3L2_CDKN1A


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for CREB3L2_CDKN1A


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
TgeneCDKN1AP38936DB01169Arsenic trioxideCyclin-dependent kinase inhibitor 1small moleculeapproved|investigational

Top

RelatedDiseases for CREB3L2_CDKN1A


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneCDKN1AC0007138Carcinoma, Transitional Cell2CTD_human
TgeneCDKN1AC0021841Intestinal Neoplasms2CTD_human
TgeneCDKN1AC0024121Lung Neoplasms2CTD_human
TgeneCDKN1AC0033578Prostatic Neoplasms2CTD_human
TgeneCDKN1AC0005695Bladder Neoplasm1CTD_human
TgeneCDKN1AC0009375Colonic Neoplasms1CTD_human
TgeneCDKN1AC0019693HIV Infections1CTD_human
TgeneCDKN1AC0022658Kidney Diseases1CTD_human
TgeneCDKN1AC0023893Liver Cirrhosis, Experimental1CTD_human
TgeneCDKN1AC0030354Papilloma1CTD_human
TgeneCDKN1AC0035126Reperfusion Injury1CTD_human
TgeneCDKN1AC0038356Stomach Neoplasms1CTD_human
TgeneCDKN1AC0238288Muscular Dystrophy, Facioscapulohumeral1CTD_human
TgeneCDKN1AC0279626Squamous cell carcinoma of esophagus1CTD_human
TgeneCDKN1AC0345967Malignant mesothelioma1CTD_human